Therakind attends BIO International 2019

28 May 2019 - Therakind Limited, a specialty pharmaceutical company focused on developing niche medicines for difficult-to-treat patient groups, notes that CEO, Susan Conroy, will be attending BIO International 2019 on 3-6 June 2019 in Philadelphia, USA.  https://www.bio.org/events

 BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centres and related organizations across the United States and in more than 30 other nations. 

 Should you wish to set up a meeting during the conference, pleasecontact usor contact Dr Conroy through the BIO Convention website.

---

Enquiries:

Therakind Limited 
Susan Conroy, Chief Executive Officer
Sam Race, Finance Director

Tel: +44 (0)208 346 6035

Email: admin@therakind.com